Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3441]

The role of the workforce in implementing Choosing Wisely in cancer care

Dr Nazik Hammad - Cancer Centre of Southeastern Ontario, Kingston, Canada

The role of the workforce in implementing Choosing Wisely in cancer care ( Dr Nazik Hammad - Cancer Centre of Southeastern Ontario, Kingston, Canada )

Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic...

Dr Tanya Siddiqi - City of Hope, Duarte, USA

Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic leukaemia/small lymphocytic lymphoma ( Dr Tanya Siddiqi - City of Hope, Duarte, USA )

ASCO 2023: Lung cancer research highlights

Dr Luis Raez - Memorial Cancer Institute, Miami, USA

ASCO 2023: Lung cancer research highlights ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )

Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment

Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA

Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment ( Dr Nausheen Ahmed - The University of Kansas Cancer, Kansas, USA )

Venetoclax and ibrutinib therapy shows favourable results in the treatment of R...

Prof Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

Venetoclax and ibrutinib therapy shows favourable results in the treatment of R/R chronic lymphocytic leukaemia ( Prof Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )

Pembrolizumab benefits patients with brain metastases

Dr Priscilla Brastianos - Mass General Cancer Center, Boston, USA

Pembrolizumab benefits patients with brain metastases ( Dr Priscilla Brastianos - Mass General Cancer Center, Boston, USA )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

The parotid gland; an unusual site of colorectal cancer metastasis

Dr Paula Isabel Franco - St Luke’s Medical Center, Malina, Philippines

The parotid gland; an unusual site of colorectal cancer metastasis ( Dr Paula Isabel Franco - St Luke’s Medical Center, Malina, Philippines )

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine...

Dr Lin-Quan Tang - Sun Yat-sen University, Guangzhou, China

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine improves PFS in N2-3 nasopharyngeal carcinoma ( Dr Lin-Quan Tang - Sun Yat-sen University, Guangzhou, China )

Talazoparib plus enzalutamide shows improvement in PFS over standard of care in...

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France

Talazoparib plus enzalutamide shows improvement in PFS over standard of care in firstline HRR mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )

CDK4/6 inhibitors added to first line show no greater benefit when compared to...

Dr Gabe Sonke - Netherlands Cancer Institute, Amsterdam, Netherlands

CDK4/6 inhibitors added to first line show no greater benefit when compared to their use in second line therapy in HR+, HER2- ABC ( Dr Gabe Sonke - Netherlands Cancer Institute, Amsterdam, Netherlands )

Dostarlimab chemo combination for primary advanced or recurrent endometrial...

Prof Matthew Powell - Washington University School of Medicine, Missouri, USA

Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer ( Prof Matthew Powell - Washington University School of Medicine, Missouri, USA )

More from ecancer